AEG3482 is an antiapoptotic compound that inhibits Jun kinase activity and cell death through induced expression of heat shock protein 70.
We describe a group of small-molecule inhibitors of Jun kinase (JNK)-dependent apoptosis. AEG3482, the parental compound, was identified in a screening effort designed to detect compounds that reduce apoptosis of neonatal sympathetic neurons after NGF withdrawal. We show that AEG3482 blocks apoptosis induced by the p75 neurotrophin receptor (p75NTR) or its cytosolic interactor, NRAGE, and demonstrate that AEG3482 blocks proapoptotic JNK activity. We show that AEG3482 induces production of heat shock protein 70 (HSP70), an endogenous inhibitor of JNK, and establish that HSP70 accumulation is required for the AEG3482-induced JNK blockade. We show that AEG3482 binds HSP90 and induces HSF1-dependent HSP70 mRNA expression and find that AEG3482 facilitates HSP70 production while retaining HSP90 chaperone activity. These studies establish that AEG3482 inhibits JNK activation and apoptosis by a mechanism involving induced expression of HSP proteins.
Centre for Neuronal Survival, Montreal Neurological Institute, McGill University, Quebec, Canada.
Amir H
AH
Salehi
Stephen J
SJ
Morris
Wai-Chi
WC
Ho
Kathleen M
KM
Dickson
Genevieve
G
Doucet
Snezana
S
Milutinovic
Jon
J
Durkin
John W
JW
Gillard
Philip A
PA
Barker
D000818:Animals; D000951:Antigens, Neoplasm / Q000502:physiology; D017209:Apoptosis / Q000187:drug effects*; D016227:Benzoquinones; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D018840:HSP70 Heat-Shock Proteins / Q000096:biosynthesis*; D048031:JNK Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D047029:Lactams, Macrocyclic; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000502:physiology; D009474:Neurons / Q000166:cytology / Q000187:drug effects; D016716:PC12 Cells; D010766:Phosphorylation; D011809:Quinones / Q000494:pharmacology; D051381:Rats; D020800:Receptor, Nerve Growth Factor / Q000037:antagonists & inhibitors / Q000502:physiology; D013449:Sulfonamides / Q000494:pharmacology*; D013830:Thiadiazoles / Q000494:pharmacology*
C511717:AEG 3482; D000951:Antigens, Neoplasm; D016227:Benzoquinones; D004791:Enzyme Inhibitors; D018840:HSP70 Heat-Shock Proteins; D047029:Lactams, Macrocyclic; C120897:MAGED1 protein, human; D009363:Neoplasm Proteins; D011809:Quinones; D020800:Receptor, Nerve Growth Factor; D013449:Sulfonamides; D013830:Thiadiazoles; D048031:JNK Mitogen-Activated Protein Kinases; C001277:geldanamycin